Burden of brain cancer will continue to rise in the US ageing population
GlobalData epidemiologists forecast that more than half of all newly diagnosed cases in the US are in the age 60 and older population.
By
GlobalData Healthcare
Latest articles
All Articles
More Covid-19 clinical trials seen in 2020 compared to 2021
This year has seen a 37.7% decrease in the number of Covid-19 clinical trials compared to last year, down…
By
Covid-19 pivotal trials slightly decrease for 2021
There have been 12 fewer trials for Covid-19 categorised as pivotal or registration studies this year compared with last…
By
Twitter round-up: Dr. Toni K. Choueiri’s tweet on FDA approval of belzutifan the most popular tweet in Q3 2021
Clinical Trials Arena lists five of the most popular tweets on oncology in Q3 2021 based on data from…
By
Newly approved Scemblix continues to show advantage in updated trial results
According to data from Novartis, Scemblix has recently received FDA approval for treating CML patients and it is the…
By
Positive pivotal data for bispecific cancer immunotherapy agent mosunetuzumab
Follicular lymphoma patients have been shown to have a 46.3% progression-free survival (PFS) at 13 years. However, there is…
By
Major unmet needs in overactive bladder unlikely to be addressed in the near future
GlobalData expects there will still be a considerable level of unmet need remaining in the overactive bladder segment by…
By
Positive Phase III data push Neurocrine’s Ingrezza closer to approval in Huntington’s
Ingrezza is forecast to generate strong sales of $326m for Huntington’s disease in the US from its approval until…
By
The Omicron variant – another reason to support equitable global vaccination coverage
The gaping inequity in global vaccination rates only ensures that new Covid-19 variants such as Omicron will continue to…
By